Alzheimer's disease: targeting the cholinergic system

TH Ferreira-Vieira, IM Guimaraes… - Current …, 2016 - ingentaconnect.com
Acetylcholine (ACh) has a crucial role in the peripheral and central nervous systems. The
enzyme choline acetyltransferase (ChAT) is responsible for synthesizing ACh from acetyl …

[HTML][HTML] International Federation of Clinical Neurophysiology (IFCN)–EEG research workgroup: Recommendations on frequency and topographic analysis of resting …

C Babiloni, RJ Barry, E Başar, KJ Blinowska… - Clinical …, 2020 - Elsevier
Abstract In 1999, the International Federation of Clinical Neurophysiology (IFCN) published
“IFCN Guidelines for topographic and frequency analysis of EEGs and EPs”(Nuwer et al …

Alzheimer's disease

C Ballard, S Gauthier, A Corbett, C Brayne, D Aarsland… - the Lancet, 2011 - thelancet.com
An estimated 24 million people worldwide have dementia, the majority of whom are thought
to have Alzheimer's disease. Thus, Alzheimer's disease represents a major public health …

Novel advances in shotgun lipidomics for biology and medicine

M Wang, C Wang, RH Han, X Han - Progress in lipid research, 2016 - Elsevier
The field of lipidomics, as coined in 2003, has made profound advances and been rapidly
expanded. The mass spectrometry-based strategies of this analytical methodology-oriented …

EFNS guidelines for the diagnosis and management of Alzheimer's disease

J Hort, JT O'Brien, G Gainotti, T Pirttila… - European Journal of …, 2010 - Wiley Online Library
Background and objectives: In 2008 a task force was set up to develop a revision of the
European Federation of the Neurological Societies (EFNS) guideline for the diagnosis and …

Head size, age and gender adjustment in MRI studies: a necessary nuisance?

J Barnes, GR Ridgway, J Bartlett, SMD Henley… - Neuroimage, 2010 - Elsevier
Imaging studies of cerebral volumes often adjust for factors such as age that may confound
between-subject comparisons. However the use of nuisance covariates in imaging studies is …

Flavonoids as promising neuroprotectants and their therapeutic potential against Alzheimer's disease

T Minocha, H Birla, AA Obaid, V Rai… - Oxidative Medicine …, 2022 - Wiley Online Library
Alzheimer's disease (AD) is one of the serious and progressive neurodegenerative
disorders in the elderly worldwide. Various genetic, environmental, and lifestyle factors are …

Abnormal cortical networks in mild cognitive impairment and Alzheimer's disease

Z Yao, Y Zhang, L Lin, Y Zhou, C Xu… - PLoS computational …, 2010 - journals.plos.org
Recently, many researchers have used graph theory to study the aberrant brain structures in
Alzheimer's disease (AD) and have made great progress. However, the characteristics of the …

Inflammation and Alzheimer's disease

YJ Lee, SB Han, SY Nam, KW Oh, JT Hong - Archives of pharmacal …, 2010 - Springer
Alzheimer's disease (AD) is the most common form of dementia. It is characterized by
extracellular deposition of a specific protein, beta-amyloid peptide fibrils, and is …

Clinical practice with anti-dementia drugs: a revised (third) consensus statement from the British Association for Psychopharmacology

JT O'Brien, C Holmes, M Jones… - Journal of …, 2017 - journals.sagepub.com
The British Association for Psychopharmacology coordinated a meeting of experts to review
and revise its previous 2011 guidelines for clinical practice with anti-dementia drugs. As …